The behavior that accompanies schizophrenia and related disorders interferes with professional and social activities. As a result, schizophrenia is one of the most costly psychiatric illnesses. Direct medical costs associated with schizophrenia were estimated from the Italian National Health Service perspective. This was a multicenter observational 1-year study conducted in 14 Italian community mental health centers (CMHCs). Eligible patients were those with a diagnosis of schizophrenia or schizoaffective or schizophrenlform disorder who had been followed by the CMHCs for at least 2 years at study entry. Exactly 643 patients were enrolled in the study. The mean direct cost per year was B 6,964 (xc 27,025 for schizophrenia and « 6,587 for patients with related psychotic disorders) (1998 exchange rate U.S.$1 = xc 1.121). The present study provides further estimates of the cost of schizophrenia treatment hi Italian mental health services and highlights the variability in the single cost components across clinically defined subgroups of patients.
In everyday clinical practice, patients suffering from schizophrenia and related psychotic disorders are treated with a range of interventions, including hospital admission, drug therapy, outpatient consultations, day care services, admission to residential facilities, home visits, and laboratory tests. Each of these interventions has its costs, and schizophrenia seems to be one of the most costly serious psychiatric illnesses (Andreasen 1991) . In England, the care of patients with schizophrenia costs twice as much as the care of patients with other psychiatric disorders (Burns and Raftery 1991) and the direct costs of schizophrenia account for 2.8 percent of all attributable National Health Service (NHS) and social services expenditures (Knapp 1997) . Fattore et al. (2000) , who surveyed a community mental health service in Northern Italy, found mat patients with schizophrenia and related disorders absorbed about 60 percent of total costs and made extensive use of several types of services. Similar data were obtained by Amaddeo et al. (1997) , who showed that in the Italian system of psychiatric care, costs were significantly higher for patients with a diagnosis of schizophrenia and related disorders than for patients belonging to other diagnostic groups.
The retrospective multicenter cost-of-illness study on 99 outpatients suffering from schizophrenia carried out by Tarricone et al. (2000) demonstrated that more than half the total direct costs were attributable to community interventions. Similar findings were obtained in the retrospective phase of the Schizophrenia Consumption of Resources (SCORE) project (Garattini et al. 2001 ).
This study presents the 1-year followup phase of the SCORE project, carried out to prospectively estimate resource consumption and direct medical costs of treatment for a representative sample of subjects with schizophrenia and related disorders in Italy; in addition, the contribution of the various cost components to total costs was determined. A secondary aim of the study was to assess whether costs differed significantly between patients with schizophrenia and patients with related disorders.
Background
The Italian National Health Service (INHS) is a public service funded by general taxation that provides universal coverage and comprehensive health care free at point of delivery .
The INHS is organized into regional health authorities (RHAs) and local health authorities (LHAs). Hospitals are reimbursed by the INHS according to a national diagnosis-related group (DRG)-like system. National tariffs should cover the full cost of hospital admissions. Although they were set up on the basis of the results of a cost survey on a limited sample of hospitals (Taroni 1996) , they have been adopted throughout the country. However, while private hospitals are reimbursed by only tariffs, any public hospital deficits are still covered by LHAs. Therefore, tariffs cannot be considered the only source of funding for public hospitals.
The 20 RHAs can add on further tariffs for specific activities (e.g., psychiatric services) that are not covered by national tariffs. Each of the 198 Italian LHAs has a mental health service. The local mental health service comprises one psychiatric ward in the general hospital (PWGH) and a network of outpatient community mental health centers (CMHCs), each serving a population of 25,000 to 150,000. Multidisciplinary teams ensure continuity of care through inpatient and outpatient treatment, providing domiciliary and rehabilitative care in close conjunction with the general hospital and its district. The local mental health service may in addition have day care centers and community residential facilities (CRFs), where patients with housing problems are admitted for medium-term periods; their presence and distribution across the country vary widely. Patients are expected to have their first contact with the CMHC of their catchment area; then, depending on symptoms, social needs, and patient preferences, they are usually followed as outpatients by the CMHC and referred to the local PWGH for acute phases, or to the local CRF for psychosocial problems and residential needs. CRFs give strong priority to patients with severe mental disorders, independent of the diagnosis (Percudani et al. 2002) . Patients can be referred to private facilities offering short-and medium-term residential care, but this option is not common, and usually these patients are referred back to the CMHC (Barbato 1998) . It is therefore very unlikely for patients with schizophrenia or other severe mental disorders not to be in contact with the CMHC of their catchment area.
Methods
The SCORE project is a multicenter observational study conducted in 14 Italian CMHCs, 7 from the north of Italy and 7 from the south. All the CMHCs participated on a voluntary basis. During the recruitment phase (September-December 1998), psychiatrists were asked to enter all patients who attended a followup consultation with a diagnosis of schizophrenia or related disorders (schizoaffective and schizophreniform), defined according to DSM-IV criteria (First et al. 1996) , and who had been followed by the CMHCs for at least 2 years at study entry. No criteria for exclusion were established. Each CMHC selected between 40 and 60 patients. Patients were classified into two groups: schizophrenia, and related psychotic disorders.
Cost Estimates. Costs included admissions in PWGH and private hospitals, day-hospital days, day care center days, days in CRFs, outpatient consultations, diagnostic procedures and laboratory tests prescribed in CMHCs, home visits, and drug therapy prescribed in CMHCs. The estimates of the direct medical costs associated with schizophrenia have been taken in the INHS perspective. Thus, indirect costs related to loss of production were not included.
Resource Consumption. Data were collected as part of routine clinical practice. At enrollment, a psychiatrist in each CMHC completed a questionnaire with the main demographic and clinical information for each patient enrolled. Patients were followed for 1 year. The psychiatrist prospectively collected information on the patients' use of health care resources using a predesigned questionnaire. The data collection was organized in quarters.
Unit Costs. Admissions, day-hospital days, and consultations in PWGH were priced using data from a microcosting study (Roggeri et al. 2001 ) carried out in a participating CMHC in the north of Italy that used the full-cost method (Garattini et al. 1999) to estimate the average cost of a day spent in PWGH 0x276.82), of a day-hospital day (H304.71), and of a consultation (n56.81). We excluded inpatient drug treatment and diagnostic and laboratory test expenditures from the microcosting analysis because we assessed these separately in the SCORE study.
Unit costs for admissions to private hospitals were priced using the Italian DRG (xr2,934.50). Because the INHS reimbursement tariff list of psychiatric interventions is not complete, we used national tariffs when available, and we integrated the national list by using the tariffs established by the Lombardy region-the most complete regional tariff list-to estimate each single psychiatric service.
Psychiatric consultations (a 19.40), social worker and nurse consultations (n 12.91) in the community, and all diagnostic tests were priced by applying the INHS tariffs. Day care center days, home visits, and days in CRFs were priced using the regional tariffs (nlO3. 3O, xr51.60, and M 103.30, respectively) . Drug costs were calculated by multiplying the daily dose by the public price for each active ingredient (Italian Directory of Medicines and Manufacturers 1997).
Data Analysis. The mean number of admissions to PWGH and private hospitals, laboratory tests, diagnostic procedures, outpatient consultations, day-hospital days, day care center days, home visits, and days in CRFs were calculated. Total costs for each patient were determined by multiplying the units of resources consumed by the specific unit costs. Mean costs per patient per year and their confidence intervals were then calculated. Confidence intervals for admissions in PWGH and private hospitals, day-hospital days, day care center days, and diagnostic procedures were based on Poisson distribution because these events were rare (mean < 1).
The chi-square Pearson's test was performed to assess the significance of differences among the baseline characteristics in the subgroups, and the Wilcoxon sumrank test (a nonparametric method) was used to assess the differences between costs.
Results
A total of 643 patients were enrolled in the study and followed for 1 year. Thirty-four subjects dropped out because they moved or were lost to followup.
Patients' characteristics are presented in table 1. More than 60 percent of subjects with schizophrenia were males, while in the group of patients with related psychotic disorders there were slightly more females (p = 0.006). The mean age was around 40 years in both groups, with a mean duration of illness, at study entry, of around 10 years. More patients with schizophrenia were unemployed or had a monthly disability contribution (p = 0.001). In both groups the most frequent level of schooling was secondary school. Table 2 shows the resource consumption per patient in the year of observation. Outpatient consultations absorbed the most resources in the two groups (almost all patients had at least one outpatient consultation during the year). Only 12 percent of patients with schizophrenia and 24 percent of those with related psychotic disorders were admitted to PWGH, and the mean number of admissions per patient per year was 0.2 and 0.4, respectively. Slightly less than 14 percent of patients with schizophrenia and 9 percent with related psychotic disorders were treated in CRFs, and the mean number of days per patient per year was 32.4 and 17.2, respectively. Almost half the sample had at least one home visit, and nearly one-third needed laboratory tests during the study. Table 3 shows the average cost per patient per year. The main components of the total direct cost for the sample analyzed were CRFs (45.0%) and admissions (21.6%), followed at some distance by drug therapy (12.0%), outpatient consultations (10.7%), and home visits (9.7%). The main cost component for schizophrenia was CRFs (47.7%), followed by admissions to hospital (19.9%), while for the related psychotic disorder group there were 32.6 percent for hospital admissions and 27.0 percent for CRFs.
The Wilcoxon sum-rank test showed significant differences between the two groups for total costs (p = 0.0363) and for the components of hospital admissions (p = 0.001), day-hospital days (p = 0.043), laboratory tests (p = 0.004), and drug therapy (p = 0.013).
Finally, table 4 shows the average cost per patient for drugs. As expected, the cost of psychotropic drugs was higher for atypical than for typical antipsychotic drugs, and for new than for old antidepressants.
Discussion
This study is a bottom-up cost analysis of the management of schizophrenia and related psychotic disorders in a sample of Italian CMHCs.
A first limitation of this study is that the participating centers were not randomly selected. Centers were located in the north and south of Italy; there were none from the nation's center. Although this might have somewhat reduced the general applicability of the findings, the structure of psychiatric services in Italy does vary widely at the local level, even in the same part of the country. In the retrospective phase of the present study, differences in total costs for the 14 participating centers were estimated, taking into account the differences in case mix . In comparison with a reference site, significant differences emerged in 6 centers, 3 from the north and 3 from the south. This figure does not support the idea that community psychiatric services in the south of Italy are not as well developed as in the north, and differences are likely to be explained more by the different local policies and regu- lations implemented during the last 20 years than by affluence. It is therefore likely that the sample of services enrolled in the present study is fairly representative of the heterogeneous organization of mental health care in Italy.
A second limitation is that, although these community services were asked to enroll patients on the basis of a DSM-IV diagnosis, no attempt was made to ensure the reliability of the diagnoses made by the clinicians concerned. This approach might therefore have led to the recruitment of a heterogeneous population of patients. However, the major aim of this study was to estimate the resource use and costs of typical real-world patients. Note.-Cl = confidence interval (95%); CRF = community residential facility; PWGH = psychiatric ward in the general hospital. Pdsson distribution was used for confidence intervals for admissions in PWGH and private hospitals, day-hospital days, day care center days, and diagnostic procedures.
Therefore, no exclusion criteria were applied, no standardized instrument was used, and all the patients included had to have been followed by the CMHCs for at least 2 years to be eligible. It might be argued that patients with a 2-year history of treatment cannot receive a diagnosis of schizophreniform disorder. However, diagnoses in real-life settings are not always made at first contact. Patients with prodromal symptoms and/or psychosocial problems are frequently followed by CMHCs for some time before a diagnosis can be formulated. So only provisional diagnoses are often recorded, to keep an approach as conservative as possible. This may well have happened for patients with a diagnosis of schizophreniform disorder at enrollment, who had probably received this diagnosis in the 6 months before study entry, even though they had been enrolled in the CMHCs for 2 years. Therefore, we believe that the present patient population is representative of the heterogeneity of patients suffering from schizophrenia and related disorders seen every day in Italian mental health services. A third limitation is that we estimated the unit costs of health care resources in only one hospital, then used this estimate to calculate direct medical costs in all participating hospitals. Ideally, the unit cost of health care facilities should be established by a detailed microcosting study in all participating centers. However, a hard costing exercise of this sort would require cost accounting information that not all centers have available. Eventually, we selected only 1 out of the 14 centers to conduct a cost study. Obviously, this figure does not precisely reflect the real costs of schizophrenia in all hospitals. However, using the DRG tariffs only instead of the real costs would have resulted in a more biased cost estimate, because the Italian DRG tariffs do not cover the real cost of psychiatric services in the hospital (Munizza et al. 1999) .
Several studies have analyzed the cost of schizophrenia , but it is difficult to compare our results with published data. In general, international comparison of quantitative results of economic studies is difficult because of currency differences. Domestic features such as clinical practice patterns and health care system frameworks also dramatically affect consumption of resources and unit costs. Cost comparisons are further complicated by the different methods adopted . The present study found that hospital costs were a smaller proportion of total direct costs than had been found in similar international studies (Muller and Caton 1983; Davies and Drummond 1990; Evers and Ament 1995; Wyatt et al. 1995; De Hert et al. 1998 ). This might be explained by the nation's strong commitment to outpatient psychiatric care: in Italy, hospital admission is considered a last resort, to be adopted only when community care has failed.
Although differences in method must be considered, it should be easier to compare studies conducted in the same country. Our data can be compared with those of Tarricone et al. (2000) and with the retrospective phase of the SCORE project (Garattini et al. 2001) . Although total costs per patient on a yearly basis are similar in all three analyses (xt7,5OO in Tarricone et al. 2000, and xr6,924 in Garattini et al. 2001) , there are differences in the contribution of some cost components to total costs. In our study, the number of admissions was nearly five times that in Tarricone et al. (2000) . This probably mitigates Tarricone et al.'s suggestion about the widespread shift from hospitals to the community in the long-term management of patients suffering from severe mental disorders in Italy. However, our analysis suggests a progressive shift toward other forms of care, such as residential care in community facilities outside the hospital. These facilities accounted for nearly half the total cost of patients with schizophrenia.
There were some interesting differences between patients with schizophrenia and those with related psychotic disorders. We found a significantly higher proportion of females in those with related psychotic disorders, and of unemployed patients in those with schizophrenia. These differences seem to reflect the epidemiology of these conditions: schizoaffective disorder, the diagnosis of 80 percent of those with related psychotic disorders, is in fact more common among females, and unemployment is more common in patients with schizophrenia (Goldberg et al. 2001 ). These differences had some impact on the resource consumption of the various services and the related costs for patients with schizophrenia and those suffering from schizophreniform and schizoaffective disorders. Admissions accounted for a smaller proportion of total cost in the former and larger in the latter. In contrast, patients with schizophrenia received more care in CRFs. Residential facilities outside the hospital have in fact been developed to admit patients with severe psychotic symptoms and schizophrenia discharged from mental hospitals. Interestingly, costs associated with drug therapy (especially the newer antidepressant drugs) and laboratory tests were significantly higher in patients with related psychotic disorders, possibly reflecting the greater use of hospital admissions. Overall, average direct costs per patient per year were significantly higher for schizophrenia, although the impact of this 6 percent difference (H438) seems negligible from an economic perspective.
In conclusion, we believe this study offers some potentially useful information on the burden of schizophrenia in Italy. In particular, it provides further estimates of the cost of schizophrenia treatment in Italian mental health services, and it highlights the variability in the single cost components across clinically defined subgroups of patients.
